Uchida Y
Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University.
Fukuoka Igaku Zasshi. 1991 Nov;82(11):576-85.
The development of hemodialysis treatment has remarkably improved the prognosis of chronic hemodialysis (HD) patients. However, as the patient's survival time is prolonged, vascular damages due to the abnormalities of calcium and lipid metabolism and hypertension has become the important complications in HD patients. In addition to coagulation and fibrinolysis, vascular endothelial function has been pursued to clarify the pathogenesis for occurrence of thrombosis in HD patients with more than ten years' duration. Twenty-two HD patients including twelve of less than ten years' duration and ten of more than ten years' were subjected to this study. Twelve healthy controls were also involved in this study. Fibrinopeptide A (FPA) and thrombin-antithrombin III complex (TAT) as indexes of coagulation, antithrombin III (AT III) as an index of coagulation inhibitor and D-dimer as an index of fibrinolysis were measured. A special attention has been focused in changes in the levels of tissue plasminogen activator (t-PA) activity and antigen and plasminogen activator inhibitor-1 (PAI-1) as indexes of fibrinolysis capacity, representing parameters of vascular endothelial functions. Levels of FPA, TAT and D-dimer were significantly higher in HD patients when compared with those in healthy controls. In particular, levels of FPA were significantly higher in HD patients with more than ten years' duration as compared to those in HD patients with less than ten years'. AT III values were significantly lower in HD patients with more than ten years' duration than those in healthy controls. T-PA activity and antigen levels were significantly lower in HD patients than those in healthy controls. T-PA activity levels were lower in HD patients with more than ten years' duration than those in HD patients with less than ten years'. Among HD patients, a significant negative correlation was found between t-PA activity and hemodialysis duration. PAI-1 values in HD patients were not significantly differ from those in healthy controls. These results suggest that in spite of increased coagulability, fibrinolytic capacity of vascular endothelium decreased in HD patients, and that the incidence is accelerated as hemodialysis duration is prolonged. Therefore, it is concluded that long-term HD patients are in the state of a higher risk of thrombosis.
血液透析治疗的发展显著改善了慢性血液透析(HD)患者的预后。然而,随着患者存活时间的延长,由于钙和脂质代谢异常以及高血压导致的血管损伤已成为HD患者的重要并发症。除了凝血和纤溶作用外,人们一直致力于研究血管内皮功能,以阐明病程超过十年的HD患者发生血栓形成的发病机制。本研究纳入了22例HD患者,其中病程小于十年的有12例,病程超过十年的有10例。此外,还纳入了12名健康对照者。检测了作为凝血指标的纤维蛋白肽A(FPA)和凝血酶 - 抗凝血酶III复合物(TAT)、作为凝血抑制剂指标的抗凝血酶III(AT III)以及作为纤溶指标的D - 二聚体。特别关注了作为纤溶能力指标的组织纤溶酶原激活物(t - PA)活性和抗原水平以及纤溶酶原激活物抑制剂 - 1(PAI - 1)的变化,它们代表血管内皮功能参数。与健康对照者相比,HD患者的FPA、TAT和D - 二聚体水平显著更高。特别是,病程超过十年的HD患者的FPA水平显著高于病程小于十年的HD患者。病程超过十年的HD患者的AT III值显著低于健康对照者。HD患者的t - PA活性和抗原水平显著低于健康对照者。病程超过十年的HD患者的t - PA活性水平低于病程小于十年的HD患者。在HD患者中,t - PA活性与血液透析病程之间存在显著负相关。HD患者的PAI - 1值与健康对照者无显著差异。这些结果表明,尽管HD患者的凝血能力增强,但血管内皮的纤溶能力下降,并且随着血液透析病程的延长,这种发生率会加速。因此,得出结论,长期HD患者处于血栓形成风险较高的状态。